{
    "nctId": "NCT00317148",
    "officialTitle": "Phase II-III Placebo-Controlled, Study to Evaluate the Effects of DHEA on Vasomotor Symptoms (Hot Flashes) in Postmenopausal Women",
    "inclusionCriteria": "* Healthy postmenopausal women with 50 or more moderate to severe hot flushes.\n* Women between 40 to 70 years of age.\n* Must be FEMALE\n* Must have minimum age of 40 Years\n* Must have maximum age of 70 Years",
    "exclusionCriteria": "* Body mass index (BMI) of 35 kg/m2 or more.\n* Significant metabolic and endocrine diseases.\n* Diagnosis of cancer.\n* Use of steroids or drugs that interfere with the metabolism of estrogen.\n* Use of any systemic estrogen, progestin, or DHEA in the eight weeks prior to randomization.\n* Use of alternative therapies or natural products to treat postmenopausal symptoms in the four weeks prior to randomization.\n* Palpable fibroids or uterine prolapse: Grade 2 or 3.\n* Cigarette smoking"
}